Sharekhan

Krishna Institute of Medical Sciences Ltd

Wed 21/05/2025,15:51:26 | NSE : KIMS

₹ 662.7523.75 (3.72%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 643.70

Previous Close

₹ 639.00

Volume

1104023

Mkt Cap ( Rs. Cr)

₹26519.21

High

₹ 666.50

Low

₹ 635.25

52 Week High

₹ 708.00

52 Week Low

₹ 350.00

Book Value Per Share

₹ 50.03

Dividend Yield

0.00

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Krishna Institute of Medical Sciences Ltd

Your Vote -

Buy

41.57%

Hold

33.71%

Sell

24.72%

41.57%

89 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

662.75

161

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

161

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Krishna Institute of Medical Sciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Krishna Institute - Analysts/Institutional Investor Meet/Con. Call Updates

    14 May 2025, 12:15PM Krishna Institute of Medical Sciences Limited has informed the Exchange about Link of Recording
  • Krishna Institute - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    14 May 2025, 12:13PM Investor call link
  • Krishna Institute - Copy of Newspaper Publication

    13 May 2025, 12:24PM Krishna Institute of Medical Sciences Limited has informed the Exchange about Copy of Newspaper Publication
  • Krishna Institute - Investor Presentation

    12 May 2025, 8:13PM Krishna Institute of Medical Sciences Limited has informed the Exchange about Investor Presentation
  • Krishna Institute - Announcement under Regulation 30 (LODR)-Investor Presentation

    12 May 2025, 8:12PM Investor Presentation for the quarter and year ended March 31, 2025.
  • Krishna Institute - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    12 May 2025, 8:07PM Press Release on Audited (Standalone & Consolidated) financial results.
  • Krishna Institute - Press Release

    12 May 2025, 8:05PM Krishna Institute of Medical Sciences Limited has informed the Exchange regarding a press release dated May 12, 2025, titled ""Press Release on the au
  • Krishna Institute - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    12 May 2025, 7:55PM KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Offic
  • Krishna Institute - Announcement under Regulation 30 (LODR)-Change in Management

    12 May 2025, 7:46PM Re-appointment of Mrs. Y Prameela Rani
  • Krishna Institute - Appointment

    12 May 2025, 7:45PM Krishna Institute of Medical Sciences Limited has informed the Exchange regarding Appointment of Mr Y Prameela Rani as Non- Executive Independent Dire
  • Krishna Institute - Announcement under Regulation 30 (LODR)-Change in Management

    12 May 2025, 7:45PM Appointment of Secretarial and Cost Auditors
  • Krishna Institute - Re-Appointment Of Mrs. Y. Prameela Rani As An\r\nIndependent Director For The Further Period Of 5 Years W

    12 May 2025, 7:38PM Re-appointment
  • Krishna Institute Q4 net profit jumps 94.02% at Rs 93.50 cr

    12 May 2025, 7:30PM The company reported standalone net profit of Rs 93.50 crore for the quarter ended March 31, 2025 as compared to Rs 48.19 crore in the same period las
  • Krishna Institute - General Updates

    12 May 2025, 7:30PM Krishna Institute of Medical Sciences Limited has informed the Exchange about General Updates
  • Krishna Institute - General Updates

    12 May 2025, 7:29PM Krishna Institute of Medical Sciences Limited has informed the Exchange about General Updates
  • Krishna Institute - Results-Financial Result For The Quarter And Year Ended 31.03.2025

    12 May 2025, 7:28PM Results
  • Krishna Institute - Board Meeting Outcome for Outcome Of Board Meeting

    12 May 2025, 7:24PM Outcome of Board Meeting
  • Krishna Institute - Outcome of Board Meeting

    12 May 2025, 7:22PM Outcome of Board Meeting
  • Krishna Institute - Outcome of Board Meeting

    12 May 2025, 7:19PM Krishna Institute of Medical Sciences Limited has informed the Exchange regarding Board meeting held on May 12, 2025.
  • Krishna Institute - Analysts/Institutional Investor Meet/Con. Call Updates

    10 May 2025, 6:13PM Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet
  • Krishna Institute - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    10 May 2025, 6:09PM Dr. Bhaskara Rao Bollineni - Founder & Managing Director, Dr. Abhinay Bollineni - Executive Director and CEO, and Mr. Sachin Salvi - Chief Financial O
  • Krishna Institute - Board Meeting Intimation for KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED Has Informed The Exchange Abou

    2 May 2025, 1:33PM Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 ,inter
  • Krishna Institute - Board Meeting Intimation

    2 May 2025, 1:27PM KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 12-May-2025 to inter-alia consider and appro
  • Krishna Institute - Other Restructuring-XBRL

    28 Apr 2025, 8:25PM KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED has informed the Exchange regarding Other Restructuring
  • Krishna Institute - General Updates

    28 Apr 2025, 5:30PM Krishna Institute of Medical Sciences Limited has informed regarding receipt of approval under Regulation 31A of the SEBI (Listing Obligations and Dis
  • Krishna Institute - KIMS : Krishna Institute Of Medical Sciences Limited Has Informed Regarding Receipt Of Approval Under Reg

    28 Apr 2025, 5:36PM Intimation of Approval received.
  • Krishna Institute has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    19 Apr 2025, 10:10AM As of March 2025, 38.82% is owned by Indian Promoters and 61.18% by Public. <p align=justify> Institutional holds 47.39% (Insurance Companies 6.20%) a
  • Krishna Institute - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    5 Apr 2025, 12:11PM Krishna Institute of Medical Sciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Krishna Institute - Trading Window-XBRL

    24 Mar 2025, 6:21PM KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED has informed the Exchange about Closure of Trading Window
  • Krishna Institute - Trading Window

    24 Mar 2025, 6:14PM Krishna Institute of Medical Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider
  • Krishna Institute - Analysts/Institutional Investor Meet/Con. Call Updates

    24 Mar 2025, 3:04PM Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet
  • Krishna Institute - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    24 Mar 2025, 3:08PM Meeting with ICICI Prudential & ICICI Securities Limited
  • Krishna Institute - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    19 Mar 2025, 6:14PM Meeting with SMIFS Limited
  • Krishna Institute - Analysts/Institutional Investor Meet/Con. Call Updates

    19 Mar 2025, 6:12PM Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet
  • Krishna Institute - Shareholders meeting

    18 Mar 2025, 6:39PM Krishna Institute of Medical Sciences Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot
  • Krishna Institute - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    18 Mar 2025, 6:33PM Postal Ballot Voting Results
  • Krishna Institute - Analysts/Institutional Investor Meet/Con. Call Updates

    10 Mar 2025, 2:12PM Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet
  • Krishna Institute - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    10 Mar 2025, 2:17PM Meeting with Capital Group
  • Krishna Institute - Analysts/Institutional Investor Meet/Con. Call Updates

    5 Mar 2025, 2:32PM Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet
  • Krishna Institute - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    5 Mar 2025, 2:36PM Meeting with Wasatch Global Investors
  • Krishna Institute - General Updates

    2 Mar 2025, 11:06AM Krishna Institute of Medical Sciences Limited has informed the Exchange about Intimation of the order received from the Regional Director (South-East
  • Krishna Institute - Krishna Institute Of Medical Sciences Limited Has Informed The Exchange About Intimation Of The Order Rec

    2 Mar 2025, 11:09AM Intimation of the order received from Regional Director (South-East Region)
  • Krishna Institute - Analysts/Institutional Investor Meet/Con. Call Updates

    22 Feb 2025, 12:47PM Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet
  • Krishna Institute - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    22 Feb 2025, 12:33PM Intimation of Investor Meet
  • Krishna Institute enters into an operations & management agreement with Splendid Hospitals

    20 Feb 2025 , 11:40AM Operation & Management Agreement with Splendid Hospitals Pvt. Ltd
  • KIMS Hospitals enters into a strategic partnership with UAIMS Hospital

    18 Feb 2025 , 11:32AM KIMS Hospitals enters into a strategic partnership with Ushahkal Abhinav Institute of Medical Sciences (UAIMS Hospital)
  • Krishna Institute of Medical Science

    18 Feb 2025 , 10:41AM KIMS: Company signs 7-year management agreement with UAIMS Hospital in Sangli, Manharashtra. It now has 4 hospitals in Maharashtra.
  • KIMS signs MoU with Wipro GE Healthcare

    18 Oct 2024 , 2:13PM KIMS signs MoU with Wipro GE Healthcare Valuing Up To Rs. 700 crore
  • Krishna Institute of Medical Science

    31 May 2024 , 12:05PM KIMS HOSPITALS announces expansion by setting up of 350 bed Super Specialty Hospital in Bengaluru, Karnataka at People Education Society (PES). PES is a university of repute and conducts several educational courses in various parts of the country. PES is in the process of setting up a medical college along with a teaching hospital at its campus at Electronics City, Bengaluru. PES is undertaking the construction and development of the building to house an approximately 350 bedded hospital, comprising of Ground Floor and 11 Upper Floors, totally measuring 3,50,000 square feet of built-up area, along with utility area and bunker for radiation oncology. KIMS Hospital Bengaluru Pvt. Ltd, a subsidiary of Krishna Institute of Medical Sciences Limited (KIMS) entered into a lease deed of 25 years and availed on lease the land and hospital building, for the purposes of setting up the Super Specialty Hospital from PES. (Positive)
  • Krishna Institute of Medical Sciences

    2 Aug 2023 , 2:05PM The company informed that it has made further investments in Sarvejana Healthcare Pvt Ltd. (Sunshine Hospital), a subsidiary of the company, by acquiring additional 2.49% stake in the company as a strategic investment. As a result, the company now owns 59.1% shareholding in Sarvejana. Sunshine Hospital generated sales of Rs. 288.3 Cr in FY23. The deal values Sunshine Hospital at 4.9x its FY23 sales. Positive read through. We do not have it in coverage.

Key fundamentals

Evaluate the intrinsic value of Krishna Institute of Medical Sciences Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 2876 2192.742 1635.029 1395.956 1027.669
Liabilities 2876 2192.742 1635.029 1395.956 1027.669
Equity 80 80.028 80.028 80.028 77.593
Gross Profit 416.5 364.407 360.283 396.22 304.029
Net Profit 302.9 235.341 252.489 278.367 188.649
Cash From Operating Activities 293.6 262.389 269.962 284.374 291.349
NPM(%) 21.88 19.25 22.3 24.34 20.22
Revenue 1384.1 1222.054 1132.023 1143.376 932.689
Expenses 967.6 857.647 771.74 747.156 628.66
ROE(%) 15.12 11.75 12.61 13.9 9.42

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Krishna Institute of Medical Sciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 810.15 -0.84 26.88 364.58 301.39 0.62
Lotus Eye Hospital and Institute Ltd 74.06 0.78 308.58 1328.47 14.01 0.68
Vaishali Pharma Ltd 12.85 -1.15 428.33 684.74 2.76 0.00
Astec Lifesciences Ltd 701.25 -1.59 0.00 1252.63 -687.11 0.00

Company Info

The Company was incorporated as `Jagjit Singh and Sons Private Limited', a private limited company under the Companies Act, 1956, with a certificate of incorporation issued by the Registrar of Companies, Maharashtra on July 26, 1973 at Mumbai. the Company changed the location of its registered office from the State of Maharashtra to the erstwhile State of Andhra Pradesh, pursuant to an order dated January 29, 2003 by the Company Law Board, Western Region Bench, Mumbai ("Order") and the registration of the Order vide certificate of registration dated February 21, 2003 by the RoC (then the Assistant Registrar of Companies, Andhra Pradesh). Subsequently, the name of the Company was changed to `Krishna Institute of Medical Sciences Private Limited', pursuant to a letter of approval from the GoI dated January 2, 2004 and a fresh certificate of incorporation issued by the RoC on January 2, 2004. Pursuant to the conversion of the Company to a public limited company, the name was changed to `Krishna Institute of Medical Sciences Limited' and the RoC issued a fresh certificate of incorporation on January 29, 2004. Until the year 2003, the Company was owned, managed and controlled by Jagjit Singh and certain of his family members, who together owned the entire shareholding of the Company. On February 15, 2003, acting in pursuance of the Takeover MoU, certain of the Promoters, namely Dr. Bhaskara Rao Bollineni and BRMH, along with certain other individuals and entities, acquired the entire equity share capital of the Company (then `Jagjit Singh and Sons Private Limited'). We have not been able to trace the complete set of documents pertaining to corporate, accounting, financial, legal and other statutory records, including any supporting documents and/or RoC filings for the period prior to the Takeover MoU. Therefore, we are unable to conclusively ascertain, amongst others, all amendments to the Memorandum of Association of the Company until February 2003.Major events and milestones of the Company :2000- KIMS Nellore established by BRMH. The business division of BRMH, including the hospital, was transferred to the Company pursuant to the 2012 Scheme.2004- KIMS Secunderabad established by the Company2010- Investment by Milestone Private Equity Fund ("MPEF") in the Company2014- KIMS Kondapur established by KHEPL, the Subsidiary*- Acquisition of 57.83% of the equity shareholding of Arunodaya Hospitals Private Limited2015- Investment by India Advantage Fund ("IAF") and Emerging India Fund ("EIF") and exit of MPEF from the Company pursuant to the share purchase agreement dated June 23, 2014 entered into between, amongst others, IAF, EIF and MPEF2017- Acquisition of KIMS Ongole by way of slump sale agreement2019- Acquisition of 51% of the equity shareholding of ICIMSPL- Acquisition of 80% of the equity shareholding of SIMSPL- Investment by General Atlantic in the Company and exit of IAF and EIF from the Company pursuant to the share purchase agreement dated June 14, 2018 entered into between, amongst others, General Atlantic, IAF and EIF2020-Acquisition of 55% of the equity shareholding of KHKPL 2022 -Krishna Institute of Medical Sciences Acquisition of 51% stake in Spanv Medisearch Lifesciences Private Limited (Kingsway Hospitals). 2023 -KIMS Hospitals, Secunderabad ranked the Second Best Multispeciality Hospital in Hyderabad by The Week Magazine. -KIMS-Kingsway Hospitals ranked the Fourth Best Multispeciality Private Hospital in Nagpur by The Week Magazine. -KIMS-Sunshine Hospitals ranked the Sixth Best Multispeciality Hospital in Hyderabad by The Week Magazine. 2024 -The Company has splits its face value from Rs. 10/- to Rs. 2/-. -The Company Informed about Acquisition of further equity stake in Sarvejana Healthcare Private Limited. -The Company has acquired 100% stake in Queen's NRI Hospital, Vizag. -The Company has informed the Exchange regarding 'Acquisition of land on a 99-year lease and purchase of building for the setting up of a new Hospital at Thane'.

The Company was incorporated as `Jagjit Singh and Sons Private Limited', a private limited company under the Companies Act, 1956, with a certificate of incorporation issued by the Registrar of Companies, Maharashtra on July 26, 1973 at Mumbai. the Company changed the location of its registered office from the State of Maharashtra to the erstwhile State of Andhra Pradesh, pursuant to an order dated January 29, 2003 by the Company Law Board, Western Region Bench, Mumbai ("Order") and the registration of the Order vide certificate of registration dated February 21, 2003 by the RoC (then the Assistant Registrar of Companies, Andhra Pradesh). Subsequently, the name of the Company was changed to `Krishna Institute of Medical Sciences Private Limited', pursuant to a letter of approval from the GoI dated January 2, 2004 and a fresh certificate of incorporation issued by the RoC on January 2, 2004. Pursuant to the conversion of the Company to a public limited company, the name was changed to `Krishna Institute of Medical Sciences Limited' and the RoC issued a fresh certificate of incorporation on January 29, 2004. Until the year 2003, the Company was owned, managed and controlled by Jagjit Singh and certain of his family members, who together owned the entire shareholding of the Company. On February 15, 2003, acting in pursuance of the Takeover MoU, certain of the Promoters, namely Dr. Bhaskara Rao Bollineni and BRMH, along with certain other individuals and entities, acquired the entire equity share capital of the Company (then `Jagjit Singh and Sons Private Limited'). We have not been able to trace the complete set of documents pertaining to corporate, accounting, financial, legal and other statutory records, including any supporting documents and/or RoC filings for the period prior to the Takeover MoU. Therefore, we are unable to conclusively ascertain, amongst others, all amendments to the Memorandum of Association of the Company until February 2003.Major events and milestones of the Company :2000- KIMS Nellore established by BRMH. The business division of BRMH, including the hospital, was transferred to the Company pursuant to the 2012 Scheme.2004- KIMS Secunderabad established by the Company2010- Investment by Milestone Private Equity Fund ("MPEF") in the Company2014- KIMS Kondapur established by KHEPL, the Subsidiary*- Acquisition of 57.83% of the equity shareholding of Arunodaya Hospitals Private Limited2015- Investment by India Advantage Fund ("IAF") and Emerging India Fund ("EIF") and exit of MPEF from the Company pursuant to the share purchase agreement dated June 23, 2014 entered into between, amongst others, IAF, EIF and MPEF2017- Acquisition of KIMS Ongole by way of slump sale agreement2019- Acquisition of 51% of the equity shareholding of ICIMSPL- Acquisition of 80% of the equity shareholding of SIMSPL- Investment by General Atlantic in the Company and exit of IAF and EIF from the Company pursuant to the share purchase agreement dated June 14, 2018 entered into between, amongst others, General Atlantic, IAF and EIF2020-Acquisition of 55% of the equity shareholding of KHKPL 2022 -Krishna Institute of Medical Sciences Acquisition of 51% stake in Spanv Medisearch Lifesciences Private Limited (Kingsway Hospitals). 2023 -KIMS Hospitals, Secunderabad ranked the Second Best Multispeciality Hospital in Hyderabad by The Week Magazine. -KIMS-Kingsway Hospitals ranked the Fourth Best Multispeciality Private Hospital in Nagpur by The Week Magazine. -KIMS-Sunshine Hospitals ranked the Sixth Best Multispeciality Hospital in Hyderabad by The Week Magazine. 2024 -The Company has splits its face value from Rs. 10/- to Rs. 2/-. -The Company Informed about Acquisition of further equity stake in Sarvejana Healthcare Private Limited. -The Company has acquired 100% stake in Queen's NRI Hospital, Vizag. -The Company has informed the Exchange regarding 'Acquisition of land on a 99-year lease and purchase of building for the setting up of a new Hospital at Thane'.

Read More

Parent Organisation

Krishna Institute of Medical Sciences Ltd.

Founded

26/07/1973

Managing Director

Dr.Abhinay Bollineni

NSE Symbol

KIMSEQ

FAQ

The current price of Krishna Institute of Medical Sciences Ltd is ₹ 662.75.

The 52-week high for Krishna Institute of Medical Sciences Ltd is ₹ 666.50 and the 52-week low is ₹ 635.25.

The market capitalization of Krishna Institute of Medical Sciences Ltd is currently ₹ 26519.21. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Krishna Institute of Medical Sciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Krishna Institute of Medical Sciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Krishna Institute of Medical Sciences Ltd shares.

The CEO of Krishna Institute of Medical Sciences Ltd is Dr.Abhinay Bollineni, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT